Titermax: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 02:53, 18 March 2025
Titermax is a type of adjuvant used in immunology to enhance the body's immune response to an antigen. It is commonly used in vaccine production to increase the effectiveness of the vaccine.
Composition[edit]
Titermax consists of two main components: a copolymer of polyoxypropylene (POP) and polyoxyethylene (POE), and a nonionic block copolymer surfactant. The POP/POE copolymer forms a microparticulate matrix, while the surfactant stabilizes the matrix and facilitates the incorporation of the antigen.
Mechanism of Action[edit]
The exact mechanism of action of Titermax is not fully understood. However, it is believed to work by enhancing the presentation of the antigen to the immune system, thereby stimulating a stronger and more prolonged immune response.
Uses[edit]
Titermax is used in the production of various types of vaccines, including those for influenza, hepatitis B, and human papillomavirus (HPV). It is also used in research to study the immune response to various antigens.
Side Effects[edit]
Like all adjuvants, Titermax can cause side effects. These can include local reactions at the injection site, such as redness, swelling, and pain. Systemic side effects can include fever, chills, and body aches.


